Companies Dominating the Immunoprotein Diagnostic Testing Landscape
- Thermofisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Abbott Laboratories
- Abcam plc
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- DiaSorin S.p.A
- Enzo Biochem
- Ortho Clinical Diagnostics
- KSL Diagnostics Inc.
- KSL Beutner Laboratories
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Immunoprotein Diagnostic Testing Market in 2025 is estimated at USD 9.96 billion.
The global market size surpassed USD 9.38 billion in 2024 and is projected to witness a CAGR of more than 7.7%, crossing USD 24.6 billion revenue by 2037.
Asia Pacific is set to cross USD 8.61 billion by 2037, attributed to rapid economic development and improvements in the medical health systems in China and India.
The major players in the market include of Bio-Rad Laboratories, Inc, Danaher Corporation, DiaSorin S.p.A, Enzo Biochem, Ortho Clinical Diagnostics, KSL Diagnostics Inc., KSL Beutner Laboratories.
